Ingredient Science
Apple Cider Vinegar, Explained: The Formula's Only Disclosed-Dose Ingredient
In Short
Apple Cider Vinegar, disclosed at 250mg per gummy, is the ingredient most directly connected to AlkaTide's craving and metabolism claims.
Understanding what the research genuinely shows helps set realistic expectations for this formula.
What the research actually says
Apple Cider Vinegar (ACV) has been studied across several clinical trials for its effects on weight, blood sugar and cholesterol, with generally positive but mixed results:
- Weight: a 2024 trial found daily ACV use over 12 weeks was linked to reduced weight, body mass index and body fat in overweight adults.
- Blood sugar: a 2023 study in people with type 2 diabetes found 30mL of ACV daily over 8 weeks lowered fasting blood sugar compared to a control group.
- Cholesterol: a 2021 review of nine trials found ACV improved total cholesterol and lipid profiles in adults.
- Broader review: a 2025 review of 25 trials found positive effects on fasting blood sugar, hemoglobin A1C and total cholesterol.
General background on ACV research is also indexed on PubMed.
An important caveat: dose matters
Most of this research used liquid ACV at meaningfully higher doses than 250mg — several studies used 15 to 30mL (roughly 15,000 to 30,000mg) of liquid vinegar daily. AlkaTide's 250mg gummy dose is considerably smaller than the amounts used in the clinical research cited above. This does not mean the gummy has no effect, but the research base was not built around this specific concentrated dose or delivery format.
Applying this to AlkaTide
Apple Cider Vinegar is the only ingredient in AlkaTide's formula with a disclosed amount (250mg per gummy) — a genuinely well-studied compound, though at a considerably lower dose than most of the clinical research behind it.
About this article: written by the AlkaTide Wellness Desk for general information. It is not medical advice. This is an independent site and earns a commission on purchases through links to the official seller — see our editorial standards.
